UBS Group’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-82,016
| Closed | -$3.15M | – | 8980 |
|
2023
Q2 | $3.15M | Buy |
82,016
+5,028
| +7% | +$193K | ﹤0.01% | 2291 |
|
2023
Q1 | $1.78M | Buy |
76,988
+8,224
| +12% | +$190K | ﹤0.01% | 2698 |
|
2022
Q4 | $1.8M | Buy |
68,764
+45,316
| +193% | +$1.19M | ﹤0.01% | 2642 |
|
2022
Q3 | $461K | Buy |
23,448
+9,322
| +66% | +$183K | ﹤0.01% | 3436 |
|
2022
Q2 | $248K | Sell |
14,126
-60,288
| -81% | -$1.06M | ﹤0.01% | 3793 |
|
2022
Q1 | $1.22M | Buy |
74,414
+29,388
| +65% | +$481K | ﹤0.01% | 3060 |
|
2021
Q4 | $735K | Buy |
45,026
+19,944
| +80% | +$326K | ﹤0.01% | 3684 |
|
2021
Q3 | $320K | Buy |
25,082
+23,958
| +2,131% | +$306K | ﹤0.01% | 3979 |
|
2021
Q2 | $16K | Buy |
+1,124
| New | +$16K | ﹤0.01% | 6502 |
|
2021
Q1 | – | Sell |
-380
| Closed | -$6K | – | 8378 |
|
2020
Q4 | $6K | Hold |
380
| – | – | ﹤0.01% | 6764 |
|
2020
Q3 | $5K | Sell |
380
-3,453
| -90% | -$45.4K | ﹤0.01% | 6472 |
|
2020
Q2 | $44K | Sell |
3,833
-4,798
| -56% | -$55.1K | ﹤0.01% | 5131 |
|
2020
Q1 | $118K | Sell |
8,631
-8,596
| -50% | -$118K | ﹤0.01% | 4295 |
|
2019
Q4 | $102K | Buy |
17,227
+9,229
| +115% | +$54.6K | ﹤0.01% | 4969 |
|
2019
Q3 | $42K | Buy |
7,998
+4,685
| +141% | +$24.6K | ﹤0.01% | 5346 |
|
2019
Q2 | $26K | Buy |
3,313
+414
| +14% | +$3.25K | ﹤0.01% | 5576 |
|
2019
Q1 | $58K | Buy |
2,899
+1,871
| +182% | +$37.4K | ﹤0.01% | 4639 |
|
2018
Q4 | $14K | Sell |
1,028
-27
| -3% | -$368 | ﹤0.01% | 6134 |
|
2018
Q3 | $39K | Buy |
1,055
+807
| +325% | +$29.8K | ﹤0.01% | 5456 |
|
2018
Q2 | $9K | Sell |
248
-307
| -55% | -$11.1K | ﹤0.01% | 6290 |
|
2018
Q1 | $25K | Sell |
555
-2,403
| -81% | -$108K | ﹤0.01% | 5396 |
|
2017
Q4 | $111K | Sell |
2,958
-3,483
| -54% | -$131K | ﹤0.01% | 4352 |
|
2017
Q3 | $343K | Buy |
6,441
+6,177
| +2,340% | +$329K | ﹤0.01% | 3694 |
|
2017
Q2 | $15K | Hold |
264
| – | – | ﹤0.01% | 5560 |
|
2017
Q1 | $14K | Sell |
264
-1,635
| -86% | -$86.7K | ﹤0.01% | 5496 |
|
2016
Q4 | $108K | Buy |
1,899
+1,608
| +553% | +$91.5K | ﹤0.01% | 4355 |
|
2016
Q3 | $18K | Sell |
291
-205
| -41% | -$12.7K | ﹤0.01% | 5496 |
|
2016
Q2 | $29K | Sell |
496
-1,560
| -76% | -$91.2K | ﹤0.01% | 5100 |
|
2016
Q1 | $131K | Buy |
2,056
+1,582
| +334% | +$101K | ﹤0.01% | 4056 |
|
2015
Q4 | $67K | Buy |
474
+326
| +220% | +$46.1K | ﹤0.01% | 4526 |
|
2015
Q3 | $14K | Buy |
148
+97
| +190% | +$9.18K | ﹤0.01% | 5726 |
|
2015
Q2 | $8K | Buy |
+51
| New | +$8K | ﹤0.01% | 6099 |
|